908 Devices Inc.

NASDAQ:MASS

Medical - Devices

Healthcare
$9.52 +2.51%

+$0.22 today

Market cap
$395.86M
Beta
0.64
P/E (TTM)
-9.0
EPS (TTM)
-$0.97
52W Low $5.03High $9.34

Volume 0.25M

Average 0.27M

MASS Pre-Tax Margin

Income before tax as a percentage of revenue.

908 Devices Inc.NASDAQ: MASS

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to -89.3%

Pre-tax margin was -89.3% in Q1 FY2026, down 5.8 pp from a year earlier. On a trailing-twelve-month basis it was -61.2%, up 45.9 pp year over year. Over 3 fiscal years it widened by 12.3 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-89.3%-114.2 pp QoQ
Last fiscal yearDec 2025
-59.3%+62.2 pp YoY
LTMMar 2026
-61.2%+45.9 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-5.8 pp——
1 year+62.2 pp——
3 years+12.3 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-59.3%
Year-over-year change
+62.2pp

Pre-Tax Margin vs competitors

How MASS compares with its peers on the latest reported figures

  • MASS's LTM Mar 2026 pre-tax margin of -61.2% is the lowest of the 3 companies compared; the peer median is 22.2%.
  • Its year-over-year change of +45.9 pp is the highest of 3, against a peer median of -0.0 pp.
  • Over three fiscal years its change of +12.3 pp compares with a peer median of -0.9 pp.
MASS Competitors Peer median
Pre-Tax Margin for MASS and competitors
Company Period LTM level YoY 3-year change
AAgilent Technologies, Inc.LTM Jul 202622.5% +2.0 pp-1.3 pp
QGENQiagen N.V.LTM Jun 202622.0% -2.0 pp-0.5 pp
MASS908 Devices Inc.LTM Mar 2026-61.2% +45.9 pp+12.3 pp
Peer median (excluding MASS) 22.2%-0.0 pp-0.9 pp

Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue42.21M46.85M50.23M59.63M56.2M
Cost of Revenue18.97M20.83M24.91M29.71M29.4M
Gross Profit23.23M26.02M25.32M29.93M26.8M
Gross Margin55.0%55.5%50.4%50.2%47.7%
Research & Development13.07M17.53M21.9M25.5M13.8M
Selling, General & Admin32.24M43.88M0037.18M
Operating Expenses45.3M61.41M68.08M106.64M50.98M
Depreciation & Amortization925K1.61M2.38M4.68M4.47M
EBITDA(20.76M)(31.82M)(40.27M)(43.88M)(28.88M)
EBITDA Margin-49.2%-67.9%-80.2%-73.6%-51.4%
Operating Income(22.07M)(35.38M)(42.76M)(76.72M)(24.18M)
Operating Margin-52.3%-75.5%-85.1%-128.7%-43.0%
Interest Income548K2.03M6.48M4.49M4.14M
Interest Expense486K129K201K00
Other Income / Expenses(100K)1.82M6.15M4.23M(9.16M)
Income Before Tax(22.17M)(33.56M)(36.61M)(72.49M)(33.34M)
Pre-Tax Margin-52.5%-71.6%-72.9%-121.6%-59.3%
Income Tax Expense00(211K)(282K)(66K)
Net Income(22.17M)(33.56M)(36.4M)(72.21M)(36.64M)
Net Margin-52.5%-71.6%-72.5%-121.1%-65.2%
EPS (Basic)(0.79)(1.07)(1.13)(2.12)0.54
EPS (Diluted)(0.79)(1.07)(1.13)(2.12)0.54
Weighted Avg Shares27.96M31.49M32.21M34.08M36.22M
Weighted Avg Shares (Diluted)27.96M31.49M32.24M34.08M38.92M

908 Devices Inc.

NASDAQ:MASS

Intrinsic Alpha fair value

Locked

Current Price

$9.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.